Description
Dapagliflozin, Glimepiride and Metformin Hydrochloride (Extended Release) Tablets MG1 is a triple-combination antidiabetic medication containing Dapagliflozin, Glimepiride, and Metformin in an extended-release formulation. It is used to improve blood glucose control in adults with Type 2 Diabetes. The combination works through complementary mechanisms to help lower blood sugar levels, enhance insulin effectiveness, and support long-term diabetes management.
Dosage
Use as directed by the physician.
Indications
Management of Type 2 Diabetes Mellitus in adults
Improvement of glycemic control when diet and exercise alone are insufficient
Patients requiring combination therapy with Dapagliflozin, Glimepiride, and Metformin
Long-term diabetes management under medical supervision
Find answers to the most common questions about our services.